What is Lu AA24530 used for?

Lu AA24530 is indicated for Treatment of schizophrenia.

Who makes Lu AA24530?

Lu AA24530 is developed by H. Lundbeck A/S.

What are the side effects of Lu AA24530?

Common side effects include Nausea, Headache, Dizziness.

Last reviewed 2026-04-23 · How we verify

Lu AA24530

H. Lundbeck A/S · Phase 2 active Small molecule

Selective 5-HT6 receptor antagonist

Selective 5-HT6 receptor antagonist Used for Treatment of schizophrenia.

At a glance

Generic name	Lu AA24530
Sponsor	H. Lundbeck A/S
Drug class	Serotonin receptor antagonist
Target	5-HT6 receptor
Modality	Small molecule
Therapeutic area	Neurology
Phase	Phase 2

Mechanism of action

Lu AA24530 is a selective 5-HT6 receptor antagonist, which is believed to exert its therapeutic effects by modulating the activity of the 5-HT6 receptor in the brain.

Approved indications

Treatment of schizophrenia

Common side effects

Nausea
Headache
Dizziness

Key clinical trials

Dose-finding Study With Lu AA24530 in Major Depressive Disorder (PHASE2)

Primary sources

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.

Source	Used for
ClinicalTrials.gov	Trial enrolment, design, endpoints, results